SCHEMBL3367906

SCHEMBL3367906

O=Cc1cc(-c2ccc3c(c2)OCO3)n(S(=O)(=O)c2cccc(Cl)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLRA3 O75311 1/20 0.41
GLRB P48167 1/20 0.41
HTR6 P50406 9/20 0.41
ALDH1A1 P00352 4/20 0.39
HSD17B10 Q99714 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39
HTT P42858 1/20 0.39
KDM1A O60341 1/20 0.39
MAOA P21397 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP3A4 P08684 1/20 0.38
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
MMP2 P08253 1/20 0.38
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3368457 0.85 GLRA3 (0.42) GLRA3GLRBHTR6ALDH1A1HSD17B10
SCHEMBL17520500 0.82 FYN (0.45) ALDH1A1HSD17B10TDP1LMNAPKM
SCHEMBL3370217 0.82 MAPT (0.45) ALDH1A1HSD17B10TDP1LMNAPKM
SCHEMBL4455226 0.79 CHEK2 (0.40) GLRA3GLRBALDH1A1HSD17B10LMNA
SCHEMBL3370190 0.77 GLRA3 (0.39) GLRA3GLRBHTR6ALDH1A1HSD17B10
SCHEMBL1156540 0.75 PKM (0.52) ALDH1A1LMNAPKMHTTMEN1
SCHEMBL3368757 0.74 HTR6 (0.44) HTR6ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL29265328 0.73 HTR6 (0.43) HTR6ALDH1A1MEN1KMT2ACYP3A4
SCHEMBL30339810 0.73 HTR6 (0.43) HTR6ALDH1A1MEN1KMT2ACYP3A4
SCHEMBL2409482 0.71 PKM (0.41) GLRA3GLRBALDH1A1HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628957-B1 SULFOPYRROLES TAKEDA PHARMACEUTICAL (JP) 2010-09-29 EP disclosed
US-7612064-B2 Sulfopyrroles TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-03 US disclosed
US-20070060570-A1 Sulfopyrroles TALEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-15 US disclosed
EP-1628957-A1 SULFOPYRROLES Takeda Pharmaceutical Company Limited (JP) 2006-03-01 EP disclosed
WO-2004103968-A1 SULFOPYRROLES APONETICS AG (CH) 2004-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060570-A1 Sulfopyrroles TYK2, ARSA, SULT2A1 GLRA3 1851/4885GLRB 2523/4885HTR6 1949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.